Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GC Biopharma Receives WHO Pre-Qualification for BARYCELA 2023-02-20 09:38
Global Times: Small and mid-sized cities in China go through infection peak, bearing new hope for future 2023-02-01 22:45
Global Times: Having weathered epidemic storms overseas, Chinese return to hometown for safe, joyous Spring Festival reunions 2023-01-31 22:10
Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away 2023-01-31 21:41
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
Looking Back on Three Years of COVID-19 in China 2023-01-13 22:29
Global Times: Connected in recognition: Foreign ambassadors signal a welcome for China's optimized, responsible COVID policy 2023-01-11 18:24
Global Times: 'Zhang Wenhong phenomenon' shows inclusiveness of China's public opinion sphere; policymaking based on science helps nation firmly hold strategic initiative of epidemic fight 2023-01-11 17:49
Global Times: China shifts COVID policy with necessary conditions 2023-01-05 23:21
China enters new stage in COVID-19 response 2022-12-29 22:00
Global Times: Three years' hard effort to fight COVID-19 'worthwhile' 2022-12-28 21:38
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control 2022-12-14 21:30
Epidemic: Modified approach ensures maximum benefit 2022-12-13 11:42
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents 2022-11-28 22:59
Immorna Receives IND Clearance to Conduct a Phase 1/2 Study of JCXH-221, a Broadly Protective mRNA-Based COVID-19 Vaccine 2022-11-21 20:00
WuXi Vaccines Establishes New Vaccines CDMO Facility in China 2022-11-15 12:45
Traditional Chinese Medicine Lianhua Qingwen Attracted Eyes in the Annual National Conference of Pharmaceutical Society of Nigeria 2022-11-08 20:25
Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research--Findings to be Presented at SITC 2022 2022-11-07 21:00
1 2 3 4 5 20